Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies L. AaronsM. RowlandS. Vozeh Conference Report 01 January 1996 Pages: 251 - 254
Elderly patients' problems with medication T. NikolausW. KruseG. Schlierf Clinical Trials 01 January 1996 Pages: 255 - 259
Increased risk of ischaemic heart disease mortality in elderly men using anxiolytics-hypnotics and analgesics J. MerloB. HedbladA. Melander Pharmacoepidemiology And Prescription 01 January 1996 Pages: 261 - 265
Lisinopril reduces postexercise albuminuria more effectively than atenolol in primary hypertension C. R»ngemarkT. HednerL. Lindholm Pharmacodynamics 01 January 1996 Pages: 267 - 271
Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline A. KornB. WagnerE. Moritz Pharmacodynamics 01 January 1996 Pages: 273 - 278
Design of a suitable formulation of FK613, a novel antiallergic agent, based on its pharmacokinetic and pharmacodynamic properties in healthy subjects T. UematsuS. NagashimaA. Sugiyama Pharmacodynamics 01 January 1996 Pages: 279 - 284
A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM F. BressolleL. EdnoR. Gomeni Pharmacokinetics And Disposition 01 January 1996 Pages: 285 - 292
Rectal pharmacokinetics of budesonide K. DahlströmS. EdsbäckerA. Källén Pharmacokinetics And Disposition 01 January 1996 Pages: 293 - 298
Interindividual variability in the rate of salbutamol sulphation in the human lung G. M. PacificiC. De SantiC. A. Ageletti Pharmacokinetics And Disposition 01 January 1996 Pages: 299 - 303
Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicam P. BonnabryT. LeemannP. Dayer Pharmacokinetics And Disposition 01 January 1996 Pages: 305 - 308
Biotransformation of caffeine by cDNA-expressed human cytochromes P-450 H. R. HaF. FollathS. Krähenbühl Pharmacokinetics And Disposition 01 January 1996 Pages: 309 - 315
Increase in magnesium plasma level after orally administered trimagnesium dicitrate C. WilimzigR. LatzS. Nyulassy Pharmacokinetics And Disposition 01 January 1996 Pages: 317 - 323
A pharmacokinetic-pharmacodynamic model for a muscle relaxant: atracurium V. NigrovicJ. GaspariM. Banoub Pharmacokinetics And Disposition 01 January 1996 Pages: 325 - 332